Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin versus metformin in Parkinson's disease with type 2 diabetes
ChiCTR2000029465Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sitagliptin and metformin in Parkinson's disease (PD) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: MDS-UPDRS part III score at week 52 and Mattis DRS-2 score at week 52. Planned start May 2020; status: not yet recruiting.
02
Drugs
sitagliptinmetformin
03
Conditions
Parkinson's disease (PD)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2000029465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029465.